Investing

Alector : ALEC

ALEC

Stock Data

$2.36

$0.01 (0.42%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Alector Inc is a pioneering biopharmaceutical firm focused on crafting innovative therapies for neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS. With products like AL001 and AL101 in various stages of clinical trials, Alector is at the forefront of exploring the potential of immune system activation in the brain to combat these conditions. The company collaborates with industry leaders such as GlaxoSmithKline and Adimab, LLC, enhancing its research and development capabilities. Founded in 2013, Alector is based in South San Francisco, California, demonstrating a commitment to addressing some of the most challenging medical conditions.

All Alector Articles

1 Article

Joel South | Mar 10, 2026 at 10:09 AM EDT

Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles

Three health-technology names are drawing fresh analyst attention this week as strategic partnerships and business pivots reframe the risk-reward calculus…